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Objective: Traditional negative pressure wound therapy systems can be large and           
cumbersome, limiting patient mobility and adversely affecting quality of life. PICO™, a no             
canister single-use system offers a lightweight, portable alternative to traditional negative           
pressure wound therapy, with improved clinical performance. The aim of this study was to              
determine the potential mechanism(s) of action of single-use negative pressure wound           
therapy versus traditional negative pressure wound therapy. 
Approach: Single-use negative pressure wound therapy and traditional negative pressure          
wound therapy were applied to an ​in vivo ​porcine excisional wound model, following product              
use guidelines. Macroscopic, histological and biochemical analyses were performed at          
defined healing time-points to assess multiple aspects of the healing response.  
Results: Wounds treated with single-use negative pressure displayed greater wound closure           
and increased re-epithelialisation versus those treated with traditional negative pressure. The           
resulting granulation tissue was more advanced with fewer neutrophils, reduced          
inflammatory markers, more mature collagen and no wound filler-associated foreign body           
reactions. Of note, single-use negative pressure therapy failed to induce wound edge            
epithelial hyperproliferation, while traditional negative pressure therapy compromised        
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peri-wound skin, which remained inflamed with high transepidermal water loss; features not            
observed following single-use treatment.  
Innovation: ​Single-use negative pressure was identified to improve multiple aspects of           
healing versus traditional negative pressure treatment. 
Conclusion: This study provides important new insight into the differing mode of action of              
single-use versus traditional negative pressure and may go some way to explaining the             
improved clinical outcomes observed with single use negative pressure therapy.  
INTRODUCTION 
Our skin has evolved an innate ability to rapidly and efficiently repair injury and damage.               
This wound healing response is both complex and dynamic, requiring initial inflammation            
followed by granulation tissue formation, angiogenesis, re-epithelialisation and dermal         
remodelling (1). In the elderly and diabetic these normal reparative processes are            
substantially impaired, increasing the risk of developing non-healing, “chronic” skin wounds           
(2). Chronic wounds are a significant socio-economic and clinical burden, estimated to cost             
the UK’s National Health Service more than £5 billion per year (3). The development and               
clinical implementation of therapies designed to address this ever-increasing and largely           
underappreciated area of clinical need remains a challenge (4, 5). 
Negative pressure wound therapy (NPWT) is one of the most effective and widely-used             
interventions for problematic wounds (6). In traditional application, foam or gauze is used to              
fill the wound to allow negative pressure transmission through to the wound bed. A drape is                
then applied to form a sealed system. NPWT devices generate negative pressure between -50              
and -175 mmHg (7), removing excess wound exudate via a drainage tube and preventing              
bacterial contamination (8,9). Early studies demonstrated that traditional NPWT (tNPWT)          
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promotes granulation tissue formation in pigs (10) and in the clinical setting (11,12).             
Additional, healing promoting effects of NPWT also include pulling wound margins together            
to accelerate contraction, stimulating cellular proliferation via microdeformation (13,14) and          
increasing tissue perfusion (15). Thus, NPWT is indicated for a plethora of wound types,              
including acute surgical, chronic, trauma, burns and skin grafts (7). 
Despite its versatility, traditional NPWT (tNPWT) is not without limitations (16). For            
example, tNPWT devices can be seen as cumbersome, requiring large canisters, power            
supplies and drainage tubes. The utilisation of wound fillers (e.g. foam) add complexity of              
use, create longer application times and can cause discomfort and pain upon dressing             
changes. Indeed, it has been noted that there is potential for filler fragments to remain in the                 
wound bed (17). Recently, lightweight negative pressure modalities have been developed to            
overcome some of these challenges inherent to larger tNPWT devices. One such example is a               
single-use NPWT system (sNPWT, PICO™, Smith & Nephew Wound Management, Hull           
UK), which is canister-free, portable and disposable.  
Here, we present a direct comparison of sNPWT to tNPWT in an ​in vivo porcine injury                
model, with a focus on elucidating the effects of sNPWT on specific aspects of the wound                
repair response.  
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CLINICAL PROBLEM ADDRESSED 
tNPWT has been shown to influence multiple aspects of the wound repair process, but comes               
with clinical limitations. sNPWT has been developed to overcome these limitations, but the             
mode of action remains poorly understood. Here a standardised and reproducible ​in vivo             
porcine wound model is used to explore the effects of sNPWT on specific aspects of the                
healing response, with direct comparison to tNPWT. This porcine study, in a close model of               
human wound repair, provides significant new insight into the effects of sNPWT on healing              
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MATERIALS AND METHODS 
Animal Experimentation: Young (12-14 weeks) female Landrace x Large White x Duroc            
farm pigs (n=12, ~40 kg) were prepared for surgery via intramuscular injection of Azaperone              
(2 mg/kg) and Midazolam (0.3 mg/kg) and anaesthetised with isoflurane and oxygen.            
Prophylactic amoxicillin (15 mg/kg) was administered subcutaneously on the day of           
wounding, and buprenorphine (0.01 mg/kg) was given intramuscularly post-operatively and          
subsequently according to clinical need. Back and flank skin was clipped, wet-shaved and             
disinfected with 5% chlorhexidine, and the skin wound site swabbed with 70% ethanol             
immediately prior to the creation of full-thickness, 3 cm diameter excisional wounds (two             
wounds per flank on each pig). Digital photographs were then taken for macroscopic wound              
analysis.  
Contralateral wounds were treated with sNPWT (PICO™ system with no filler, Smith &             
Nephew Wound Management, Hull, UK; -80 mmHg) or tNPWT (V.A.C Via™ system with             
Granufoam™ wound filler, KCI Medical Ltd., West Sussex, UK; -125 mmHg continuous            
mode). The PICO™ sNPWT system consists of a silicone wound interface dressing to             
transmit even pressure across the wound bed, while negative pressure in the traditional device              
was transmitted from the wound filler. sNPWT was changed every 6 days, while tNPWT was               
changed every 3 days, as per the ‘Instructions for Use’ provided with each device              
(​Supplemental Figure 1A​). A purpose made swine jacket with pockets (Lomir Biomedical            
Inc., Quebec, Canada) was used to support the NPWT device pumps on the animals.  
Wound Planimetry Analysis​: Wounds were digitally photographed at day 0 (n=12 pigs/24            
wounds per treatment group), day 6 (n=12 pigs/24 wounds per treatment group) and day 12               
(n=8 pigs/16 wounds per treatment group). Macroscopic wound closure analysis was           
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performed using Image Pro Plus v.4.1.0 (Media Cybernetics, Maryland, USA). The wound            
area remaining open, and the contribution of re-epithelialisation and contraction to overall            
wound closure were measured as described below (see also ​Figure 1A​): 
% wound area remaining open =                                                    X 100  
% contraction =                                                           X 100 
% re-epithelialisation =                                                                                                     X 100  
Skin and Wound Assessment​: Surface wound damage was determined at each dressing            
change, where 0 = no bleeding, 0.5 = removal of surface tissue without bleeding, 1 = minimal                 
bleeding, 2 = moderate bleeding and 3 = substantial bleeding. Skin colour measurements             
were taken using a spectrophotometer (X-Rite Sp68 Sphere, Manchester, UK) and expressed            
using the CIELAB colour notation system. A Tewameter® TM 300 was used to measure              
transepidermal water loss (TEWL) and skin hydration, and a Mexameter® MX 18 probe             
(both Courage and Khazaka, Germany) was used to measure erythema (using a redness             
index). These measurements were made, after sNPWT dressing or tNPWT drape removal, in             
two regions around the wound: a) the peri-wound (approximately 0.5-1 cm away from wound              
edge) and; b) the extended zone (2.5-3 cm away from wound edge). For TEWL, an average                
of the first 30 readings was taken following skin acclimatisation post-dressing removal. For             
skin hydration (skin surface moisture), a reading was taken immediately following dressing            
removal with no acclimatisation (at the extended zone site only). Wound depth was assessed              
in three defined wound regions using a depth gauge. These measurements were taken on              
n=12 pigs (24 wounds) at day 6 and n=8 pigs (16 wounds) at day 12. 
Tissue Collection​: Histological samples were collected from n=4 pigs harvested at day 6             
(n=8 wounds per treatment group) and n=4 pigs harvested at day 12 (n=8 wounds per               
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treatment group), pre-selected during study planning. Strips (1 cm wide) of wound tissue and              
marginal skin (cranio-caudal orientation) were harvested and placed in 10% buffered formal            
saline for histological analysis. Wound tissue (n=4, one wound per pig per time-point) was              
placed in RNA​later​™ (Thermo Fisher Scientific, Paisley, UK) and frozen at -80ºC for PCR              
Array profiling. Normal skin, peri-wound skin (immediately adjacent to the wound) and            
extended zone skin (under the sNPWT dressing island, or tNPWT drape) was also collected              
for comparison. 
Histology​: Paraffin embedded sections (6 µm thick) were dewaxed and rehydrated prior to             
staining. Haematoxylin and eosin (H&E) was used to visualise trapped filler material and to              
quantify granulation tissue depth and re-epithelialisation via ​Aperio ​ImageScope image          
analysis software (Leica Biosystems, Milton Keynes, UK). Picrosirius Red (PSR) colour           
analysis allowed histological assessment of matrix maturity, where immature (green          
birefringence) and mature (red birefringence) fibres were visualised via polarising light and            
quantified (as in 18). For BrdU analysis, proliferating cells were labelled 1 hour prior to               
culling ​via i.p. injection of 1 mg 5-Bromo-2’-deoxyuridine (BrdU, B5002, Sigma-Aldrich) in            
100 mL physiological saline. BrdU was traced using an anti-BrdU (Bromodeoxyuridine)           
antibody (GE Life Sciences, Buckinghamshire, UK). Neutrophils were stained using an           
anti-NGAL (neutrophil gelatinase-associated lipocalin) antibody (Enzo Life Sciences Inc,         
New York, USA). Bound antibodies were detected via ABComplex and          
3,3′-Diaminobenzidine (DAB; Vector Laboratories Ltd., Peterborough, UK). The number of          
BrdU+ve and NGAL+ve cells were determined using Image Pro Plus.  
Transcriptional Profiling​: Porcine skin and wound tissue was homogenised (T10 basic,           
IKA, Oxford, UK) in TRIzol® reagent (Thermo Fisher Scientific). Chloroform was added for             
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phase separation and RNA removed and purified using a PureLink RNA Mini Kit (Thermo              
Fisher Scientific) following manufacturer’s instructions. RNA concentration was determined         
using a SimpliNano nanodrop (Biochrom, Cambridge, UK) and adjusted to 1 µg/µL. Reverse             
transcription was performed with Random Primers (Promega, Southampton, UK) and          
Bioscript reverse transcriptase (Bioline, London, UK). cDNA was diluted in nuclease free            
water and each sample plated in RT​2 Profiler™ PCR array plates (Pig Wound Healing;              
Qiagen, Manchester, UK) with 2X Takyon SYBR mastermix (Eurogentec, Hampshire, UK).           
Quantitative real-time polymerase chain reaction (qRT-PCR) was performed and data was           
analysed in CFX Manager software on a CFX connect thermocycler (Biorad Laboratories            
Ltd., Hertfordshire, UK). 
Statistical Analyses​: All data are presented as mean +/- standard error of the mean (SEM).               
Pair-wise ​t tests were performed on data sets comparing sNPWT and tNPWT at one              
time-point. One-way ANOVA was performed on qRT-PCR data comparing normal skin and            
day 12 treatments. Two-way ANOVA was performed on all other data sets with appropriate              
post-hoc analysis (Tukey or Sidak). Statistical analysis was performed in GraphPad Prism            
v.7.0 (GraphPad Software, CA, USA). Data were considered significant at the ​P​ < 0.05 level. 
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RESULTS 
sNPWT leads to greater wound closure than tNPWT. Planimetric analysis was performed            
on scaled macroscopic wound images taken at day 0, day 6 and day 12 (​Figure 1A​). The area                  
of the wound remaining open, determined as a percentage of day 0 wound area, was               
significantly smaller following sNPWT than tNPWT at both day 6 (70.06% vs 78.55%; ​P <               
0.001) and day 12 (18.56% vs 33.36%; ​P < 0.001) post-injury (​Figure 1B​). Similarly,              
macroscopic quantification demonstrated significantly greater re-epithelialisation with       
sNPWT compared to tNPWT at days 6 (4.46% vs 0.55%; ​P < 0.01) and 12 (22.73% vs 8.4%;                  
P < 0.001; ​Figure 1C​). Wound contraction was greater at day 6 for sNPWT treated wounds                
(​P < 0.05; Figure 1D​) versus tNPWT, and was found to be similar between treatments at day                 
12. Accelerated re-epithelialisation following sNPWT treatment was confirmed by         
histological analysis of H&E stained tissue sections at day 12 (​P < 0.001; ​Figure 1E-F)​.               
Interestingly, the neo-epidermis of wounds under tNPWT was extremely hyperproliferative at           
day 12, as demonstrated by increased numbers of proliferative (BrdU+ve) cells (​P < 0.001;              
Figure 1G, I​) and increased peak epidermal thickness (​Figure 1H-I)​. Collectively, these data             
demonstrate that sNPWT accelerates wound closure compared to tNPWT, with increased           
epithelial migration and reduced wound edge hyperproliferation.  
Reduced wound bed inflammation following sNPWT treatment. Immunohistochemistry        
for neutrophils was performed to assess the level of early inflammatory cells in porcine              
NPWT-treated wounds. Quantification showed significantly higher neutrophil numbers in         
tNPWT treated wounds compared to sNPWT at day 12 post-wounding (​Figure 2A​; ​P <              
0.001). Transcriptional profiling revealed statistically significant upregulation of a number of           
pro-inflammatory cytokines including ​CXCL11 (Day 6), ​CSF2​, ​IL-1α and ​IL-1β (day 12) in             
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tNPWT treated wounds (​Figure 2B-H​). Collectively, these findings support higher wound           
bed inflammation in tNPWT versus sNPWT treated wounds. 
sNPWT promotes granulation tissue maturation and causes less damage to the wound            
bed than tNPWT​. Similar wound filling was observed between sNPWT and tNPWT at day              
6. However, by day 12 tNPWT led to significantly reduced macroscopic wound depth (​P <               
0.001; ​Figure 3A​) and increased wound granulation tissue deposition (measured by           
histology; ​P < 0.001; ​Figure 3B) compared to sNPWT. While wounds filled faster under              
tNPWT, the quality and maturity of granulation tissue formed in these wounds was inferior to               
that following sNPWT application. Picrosirius red (PSR) staining determined granulation          
tissue extracellular matrix maturity in discrete upper wound regions (​Figure ​3C-F​). Here,            
sNPWT led to significantly increased total collagen deposition (brightfield; ​P < 0.05; ​Figure             
3E​). Polarising light microscopy revealed that sNPWT treatment increased both immature           
(green birefringence) and mature (red birefringence) collagen fibre deposition compared to           
tNPWT (​P​ < 0.001; ​Figure 3D, F​).  
Wound maturation was evaluated by measuring the level of granulation tissue cellular            
proliferation. Here, sNPWT treated upper wound tissue contained fewer BrdU+ve cells           
versus tNPWT (​P < 0.001; ​Figure 3G-H​). qRT-PCR array analysis further substantiated            
increased maturity of sNPWT wounds, with higher expression of wound matrix components,            
COL1A2 (​P < 0.01; ​Figure 3I​) and ​COL3A1 (​P < 0.001; ​Figure 3J​), granulation-promoting              
factors, ​CTGF (​P < 0.001; ​Figure 3K​), and proteoglycans, ​DCN (​Figure 3L​), in sNPWT              
wounds. By contrast, tNPWT treated wounds displayed substantially elevated levels of the            
tissue remodelling matrix metalloproteinases, ​MMP3 (​P < 0.01; ​Figure 3M​) and ​MMP9 (​P <              
0.05; ​Figure 3N​), but not ​MMP2​ (​Supplementary Figure 2A​). 
11 
Brownhill et al. 
Evaluation of H&E stained sections revealed trapped filler material/foreign body reactions in            
50% of tNPWT treated wounds (representative images in ​Figure 4A​). By contrast, no             
trapped filler material or foreign body reactions were detected in any sNPWT treated wounds.              
Additionally, tNPWT dressing removal resulted in significantly more wound surface damage           
with noticeable bleeding compared to removal of sNPWT dressing at day 6 (​P < 0.001) and                
day 12 (​P < 0.001; ​Figure 4B​). Overall, these data reveal that sNPWT increased granulation               
tissue maturation, without the trapped filler and damage observed following tNPWT. 
Reduced surrounding skin disruption with sNPWT versus tNPWT​. Skin barrier function           
and erythema were assessed in the peri-wound skin and the extended zone (schematic,             
Supplementary Figure 1B​) to determine whether NPWT application affected the function of            
skin surrounding the wound. Extended zone skin hydration, measured immediately after           
dressing or drape removal, revealed significantly higher moisture content in skin under            
tNPWT compared to skin under sNPWT (​P < 0.001 at days 6 and 12; ​Figure 5A​). In                 
addition, TEWL, a direct measure of skin barrier, was significantly elevated in peri-wound             
skin under the tNPWT drape compared to that under the sNPWT dressings (​P < 0.001;               
Figure 5B​). ​The redness (erythema) of tNPWT treated peri-wound skin was significantly            
greater than sNPWT treated skin (​P < 0.001; ​Figure 5C​), with a non-significant trend              
towards an increased erythema index (​Figure 5D​). Collectively, these ​in vivo data suggest             
that sNPWT causes far less disruption to the skin surrounding a wound.  
tNPWT, but not sNPWT, causes heightened proliferation and inflammation in          
peri-wound skin​. Next, the cellular correlates to the observed reduced redness and TEWL in              
sNPWT treated peri-wound skin were assessed histologically. Reduced epidermal BrdU+ve          
(proliferating) cells were observed in the sNPWT treated peri-wound tissue at day 6 (​P <               
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0.05) and day 12 (​P < 0.05; ​Figure 6A-B​), commensurate with reduced tissue damage.              
Transcriptional analysis revealed elevated inflammation in tNPWT treated peri-wound skin          
with upregulation of the inflammatory markers ​CSF2 (​P < 0.05; ​Figure 6C​), ​IL-1α (​Figure              
6D​), ​IL-1β (​P < 0.05; ​Figure 6E​). In addition, ​MMP2 was specifically upregulated at day 6                
(​P < 0.05; ​Figure 6F​; ​Supplementary Figure 2​). Taken together, these data suggest that              
tNPWT treatment adversely influences the peri-wound skin region, while sNPWT supports a            
pro-healing wound edge environment.  
DISCUSSION 
Traditional NPWT devices were successfully implemented in wound treatment over 20 years            
ago (11,19). In these applications a wound filler (foam or gauze) is required to deliver               
negative pressure to the wound bed and to serve as a fluid conduit. As previously mentioned,                
the PICO™ sNPWT system uses a very different technology, a silicone wound interface             
dressing with an incompressible airlock layer that transmits pressure evenly across the wound             
bed, peri-wound and wider skin region (20). Interestingly, a recent randomised control trial             
demonstrated that sNPWT achieved greater wound closure (45%) compared to tNPWT           
(22%) with fewer adverse events, such as wound maceration (21). Concurrent cost-based            
analysis revealed that sNPWT was more cost-effective than tNPWT (22), suggesting benefits            
that extend beyond the patient. 
The current study was specifically designed to explore the mode of action of sNPWT              
compared to tNPWT using an ​in vivo porcine wound repair model. Note, previous studies              
(e.g. 23) have performed direct porcine side-by-side comparison of tNPWT devices           
demonstrating relative equivalence. Here we report, for the first time, detailed macroscopic            
and histological comparison of sNPWT and tNPWT ​in vivo​. We show that sNPWT             
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accelerated wound closure, promoted wound re-epithelialisation and increased granulation         
tissue maturity when compared with tNPWT. In fact, tNPWT actively prevented           
re-epithelialisation, inducing substantial wound edge epidermal hyperproliferation. tNPWT        
treated wounds also displayed extensive filler material trapped in the granulation tissue            
(observed in earlier studies; in pigs (24,25) and in patients (26-28)), which may contribute to               
heightened local tissue inflammation (29).  
NPWT-associated healing has previously been linked to dampened pro-inflammatory         
cytokines, ​TNFα and ​IL-1β​, compared to non-NPWT treatment (30,31). In our study, tNPWT             
treated wound granulation tissue displayed increased inflammation and upregulation of the           
pro-inflammatory the cytokines, ​CSF2​, ​CXCL11​, ​IL-1α and ​IL-1β​, compared to sNPWT           
treatment. The heightened damage response following tNPWT extended to the peri-wound           
skin region, which also contained increased pro-inflammatory marker expression and          
increased redness, indicative of erythema (32). This local damage likely results from both the              
differential forces experienced by tNPWT and sNPWT treated wounds, and the differences in             
frequency of dressing change. Interestingly, Karaback et al. (33) report that compressional            
injury from tNPWT drape drainage tubes can cause spontaneous wound formation in            
compromised skin surrounding a wound. 
Higher TEWL and excessive hydration were observed in the skin surrounding tNPWT treated             
wounds. TEWL is a direct measure of skin barrier integrity, where higher TEWL is              
associated with a compromised barrier (34,35). High TEWL is a potential indicator of skin              
maceration risk, an observation noted by Kirsner et al. (21) in their randomised control trial               
following tNPWT use. Loss of barrier integrity also increases the risk of infection (36), a               
common problem when negative pressure application fails and wound exudate is not            
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effectively managed (26). Indeed, in the present study, sNPWT delivered active therapy 97%             
of the time requiring only 14 device-related interventions, versus 24 interventions to correct             
leaks and blockages under tNPWT.  
In addition to neo-epidermal hyperproliferation, tNPWT caused excessive cellular         
proliferation in the peri-wound region and in the wound granulation tissue. High levels of              
epidermal proliferation are a hallmark of wound pathology, and have previously been            
observed following tape stripping (37), suggesting that tNPWT dressing removal may cause            
similar damage. By contrast, mature wound granulation tissue is typically characterised as            
relatively acellular (38). In the present study, granulation tissue of tNPWT treated wounds             
was highly proliferative, with fewer mature collagen fibres and increased wound matrix            
metalloproteinases, indicating reduced maturation compared to sNPWT. Overall, these data          
suggest that sNPWT independently promotes granulation tissue maturation and         
re-epithelialisation. Indeed, these two aspects could be closely linked, with a mature wound             
bed important to permit active re-epithelialisation.  
Data now show a direct link between compromised skin barrier and subsequent wound             
recurrence (39), a significant consideration for chronic wound management. Although several           
clinical studies have demonstrated enhanced wound closure and faster granulation with           
tNPWT (40,41), few studies have performed follow-up assessments to determine rates of            
wound recurrence (42). A future pre-clinical ​in vivo investigation would provide a unique             
opportunity to explore recurrence, an important and often overlooked aspect of wound            
healing studies.  
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INNOVATION 
The results of this pre-clinical ​in vivo study clearly demonstrate that sNPWT, which delivers              
negative pressure using a unique multi-layered interface technology, promotes faster healing           
than tNPWT. ​While tNPWT treatment led to wound damage and inflammation, sNPWT            
stimulated faster re-epithelialisation and promoted granulation tissue maturation. This study          
therefore provides new mechanistic insight that informs the enhanced wound healing           
outcomes of sNPWT observed in the clinical setting.  
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KEY FINDINGS  
● Single-use NPWT (sNPWT) promotes a faster rate of wound closure than traditional            
tNPWT (tNPWT) in an ​in vivo​ porcine model.  
● sNPWT improves multiple aspects of healing, promoting re-epithelialisation,        
dampening inflammation, and increasing granulation tissue maturity.  
● sNPWT avoids the detrimental effects of tNPWT on the peri-wound epithelium. 
● sNPWT appears to circumvent the foam-trapping and foreign body reactions that are            
frequently observed with tNPWT. 
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ABBREVIATIONS AND ACRONYMS 
BrdU – Bromodeoxyuridine 
H&E – Haematoxylin and eosin 
NPWT – Negative pressure wound therapy 
PSR – Picrosirius red  
qRT-PCR – quantitative real-time polymerase chain reaction 
sNPWT – Single-use negative pressure wound therapy 
tNPWT – Traditional negative pressure wound therapy 
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Figure 1. Single-use negative pressure wound therapy accelerates porcine wound          
closure. ​Single-use negative pressure wound therapy (sNPWT) or traditional NPWT          
(tNPWT) was applied to 3 cm diameter full-thickness excisional wounds. Representative           
macroscopic images showing the impact of treatment over time (​A; ​Bar = 1 cm).              
Macroscopic analysis was performed to determine original wound area (day 0; outer dashed             
line), wound area remaining open (inner dotted line) and wound contraction (central solid             
line). Quantification of wound area (​B​), percentage re-epithelialisation (​C​) and wound           
contraction (​D​) over time. Representative day 12 H&E images (​E; Bar = 1 mm, Arrows ​=                
length of neo-epithelium), and quantification of histological re-epithelialisation (​F​).         
Neo-epidermal proliferation (​G​) and peak neo-epidermal thickness (​H​) with representative          
BrdU staining at day 12 (​I​; Bar = 1 mm, Arrows = peak thickness). Dotted line separating                 
epidermal and dermis (​I​). Mean +/- SEM. ​B-D​, n=8-12 pigs (16-24 wounds per treatment              
group), ​F-H​, n=4 pigs (8 wounds per treatment group). * = ​P < 0.05, ** = ​P < 0.01, *** = ​P                      
27 
Brownhill et al. 
< 0.001. Two-way ANOVA was performed on ​B, C, D, F​. Independent two-tailed student’s ​t               
test performed on ​G ​and​ H​. 
Figure 2. Single-use negative pressure dampens inflammation in porcine wounds​.          
Wounds treated with traditional NPWT (tNPWT) showed increased neutrophil infiltration at           
day 12 (​A​), and higher cytokine marker expression (qRT-PCR) at day 6 and day 12               
post-wounding (​B-H​). Mean + SEM. n=4 pigs (​A​, 8 wounds per treatment group, ​B​-​H​, 4               
wounds per treatment group). * = ​P < 0.05, ** = ​P < 0.01, *** = ​P < 0.001. Independent                    
two-tailed student’s ​t test was performed on ​A​. Two-way ANOVA was performed on all              
other data sets. 
Figure 3. Porcine wound maturation is accelerated with single-use negative pressure           
wound therapy compared to traditional application​. Increased wound depth (​A​) and           
reduced granulation tissue (GT) depth (​B​) were shown following single-use negative pressure            
wound therapy (sNPWT) compared to traditional NPWT (tNPWT). Schematic depicting          
outer (O), inner (I), and central (C) histological assessment regions of wounds (​C​). Wound              
maturation was assessed at day 12. Picrosirius red staining under brightfield (BF) and             
polarised (Pol) light (​D​). Bar = 50 µm. sNPWT treatment increased BF matrix deposition (​E​)               
and increased immature (green birefringence) and mature fibres (red birefringence; ​F​). Cell            
proliferation (​G​, quantified in ​H​) within granulation tissue was higher in wounds treated with              
tNPWT. Bar = 200 µm. Arrows = proliferative cells. PCR array analysis demonstrated             
elevated matrix gene expression in sNPWT day 12 wounds (​I-L​) and reduced matrix             
metalloproteinases (​M-N​). Mean + SEM. ​A​, n=8-12 pigs (16-24 wounds per treatment            
group), ​B, E-F​, n=4 pigs (8 wounds per group), ​I​-​N​, n=4 pigs (4 wounds per group). * = ​P <                    
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0.05, ** = ​P < 0.01, *** = ​P < 0.001. Two-way ANOVA used on data sets ​A, B, E, F, H​,                      
one-way ANOVA used on data sets ​I-N​. 
Figure 4. Filler foam in traditional negative pressure wound therapy causes wound            
damage​. Traditional negative pressure wound therapy (tNPWT) left foam in wounds (​A​,            
H&E staining) and caused more wound surface damage on removal than single-use NPWT             
(​B​). 0 = no damage, 3 = substantial bleeding. Black stars = filler material. Yellow stars =                 
foreign body reactions. Bars = 100 µm. Mean + SEM. n=8-12 pigs (16-24 wounds per               
treatment group). * = ​P < 0.05, ** = ​P < 0.01, *** = ​P < 0.001. Two-way ANOVA with                    
Tukey’s ​post-hoc ​test was performed. 
Figure 5. Traditional negative pressure wound therapy increases erythema and          
transepidermal water loss in peri-wound skin. Traditional negative pressure wound          
therapy (tNPWT) increased hydration in the extended zone region (​A​) and increased TEWL             
in the peri-wound skin (​B​). tNPWT also caused more erythema (​C-D​) in the peri-wound skin               
region. NS line = normal skin value. Mean + SEM. n=8-12 pigs (16-24 wounds per treatment                
group). *** = ​P​ < 0.001. Two-way ANOVA was performed with Sidak ​post-hoc​ analysis. 
Figure 6. Traditional negative pressure wound therapy causes inflammatory damage to           
peri-wound skin. ​Traditional negative pressure wound therapy (tNPWT) increased         
peri-wound epidermal proliferation at day 6 and day 12 (​A, ​quantified in ​B​). Bar = 200 µm.                 
Arrows = BrdU+ve cells. PCR array demonstrated upregulation of inflammatory genes in the             
peri-wound skin at day 6 post-wounding (​C-F​). Mean + SEM. ​B​, n=4 pigs (8 wounds per                
treatment group), ​C-F​, n=4 pigs (4 wounds per group). * = ​P < 0.05, ** = ​P < 0.01, *** = ​P                      
< 0.001. Two-way ANOVA was performed on ​B​. Paired ​t ​tests were performed on ​C-F​. 
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Supplementary Figure 1. Experimental setup and live phase assessments. ​Single-use          
negative pressure wound therapy (sNPWT) or traditional NPWT (tNPWT) was applied to 3             
cm diameter full-thickness excisional wounds. Numbers indicate day post-injury. sNPWT          
was changed every 6 days (blue arrows) and tNPWT was changed every 3 days (red arrows)                
as per instructions for use. At day 6 and 12, live phase assessments and macroscopic               
measurements were performed (all animals), while tissue was collected for histology and            
qRT-PCR (​A​). For live phase assessment, transepidermal water loss (TEWL) and hydration            
measurements (T), and colour and erythema measurements (C), were taken from the            
peri-wound (green *), extended zone (purple *) and normal skin (red *) regions (​B​). 
Supplementary Figure 2. Negative pressure therapy differentially alters MMP         
expression. ​PCR arrays were used to assess the expression of ​MMP2​, ​MMP3 and ​MMP9 in               
wounds at day 12 (​A​) and in the peri-wound region at day 6 (​B​). NS = normal skin. tNPWT =                    
traditional negative pressure wound therapy. sNPWT = single-use NPWT. Mean + SEM. n=4             
pigs (4 wounds per group). * = ​P < 0.05, ** = ​P < 0.01, *** = ​P < 0.001. One-way ANOVA                      
was performed on ​A​. Paired ​t ​tests were performed on ​B​. 
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